TB-CRE and MTBC Melbourne Symposium 2025
Event description
Join us this coming March for the inaugural TB-CRE and MTBC Melbourne Symposium 2025!
The TB CRE and Melbourne TB Community are co-hosting a 1 ½ day research symposium (hybrid option available), targeted towards TB researchers, TB clinicians, and public health practitioners. We also welcome PhD students, early career researchers and clinicians of all career stages.
Speakers will include leading TB researchers from across Australia, sharing the findings of research underway locally and across the Asia-Pacific region. Full schedule of the one and a half day event is attached below.
Event details:
Date, Time and Venue:
World TB Day
24 Mar 2025, 3 - 5 pm
Doherty Institute, Ground floor Auditorium
25 Mar 2025, 8.30 - 5 pm
Doherty Institute, Mezzanine Seminar rooms (GM002/3)
Peter Doherty Institute for Infection and Immunity,
792 Elizabeth St, Melbourne 3000
Zoom webinar: https://unimelb.zoom.us/s/85166791192
Or join webinar with the following methods | |
Phone one-tap | |
Phone one-tap: | Australia: +61280156011,,85166791192# or +61370182005,,85166791192# |
Join by Telephone | |
For higher quality, dial a number based on your current location. | |
Dial: |
|
Webinar ID: | 851 6679 1192 |
Passcode: | 488769 |
Join from an H.323/SIP room system | |
H.323: | global.zoomcrc.com |
Webinar ID: | 851 6679 1192 |
Passcode: | 488769 |
SIP: | 85166791192@global.zoomcrc.com |
Passcode: | 488769 |
Full schedule of the one and a half day event:
Session 1: World TB Day and research
|
Time |
Presentation title |
Speaker |
|
3.00pm |
Registration (10 mins) |
|
|
3.10-3.25 |
World TB Day Public Event (large meeting room) hosted by MTBC "Unite to End TB" (10mins + 5mins Q&A) |
Chair: Dr. Khai Huang |
|
3.25-3.40 |
Asymptomatic TB: Dispelling indoctrinated assumptions and reilluminating how We Can End TB |
A/Prof. Anna Coussens |
|
3.40-3.55 |
Experiential Experts - managing TB infection and family |
Krista Watts |
|
3.55-4.10 |
Maternal TB, what we know, what we need to do |
Prof. Steve Graham |
|
A TB research agenda to end TB (10mins + 5mins Q&A) |
||
|
4.10-4.15 |
Welcome and overview of TB research to end TB |
Prof. Greg Fox |
|
4.15-4.30 |
National TB research priorities overview |
Prof. Justin Denholm |
|
4.30-4.45 |
Regional TB research priorities overview |
Prof. Ben Marais |
|
4.45-5.00 |
Q&A: TB CRE |
Dr. Khai Huang |
|
5.00pm |
Close |
Session 2: New insights into tuberculosis host and pathogen (Chair: Sarah Dunstan)
|
Time |
Presentation title |
Speaker |
|
8.30am |
Registration (25 mins) |
|
|
8.55am |
Session 2.1: Pathogen (10mins + 5mins Q&A) |
Dr. Katherine Bond |
|
9.00-9.15 |
Effect of compensatory evolution on the emergence and transmission of rifampicin-resistant TB in Cape Town, South Africa |
Prof. Helen Cox |
|
9.15-9.30 |
Predicting drug resistance direct from sputum using nanopore sequencing |
Prof. Lachlan Coin |
|
9.30-9.45 |
First national genomic characterisation of M. tuberculosis in Australia (AusPathogen) |
Dr. Kristy Horan |
|
9.45-10.00 |
Targeting Carbon Metabolism in Mycobacterium tuberculosis |
Dr. Ivanhoe Leung |
|
10.00-10.15 |
Optimising TB investments in Belarus, Moldova, Kyrgyz Republic, Tajikistan and Uzbekistan |
Dr. Rowan Martin-Hughes |
|
10.15-10.30 |
Modelling the epidemiology of TB in Vietnam |
Long Bui, PhD |
|
10.30am |
Morning tea |
|
|
Session 2.2: Host |
Prof. Ben Marais |
|
|
10.50-11.05 |
Human and Pathogen co-evolution |
A/Prof. Sarah Dunstan |
|
11.05-11.20 |
Genome-wide association study reveals a novel tuberculosis susceptibility locus in multiple East Asian and European populations |
Dr. Shirley Chang |
|
11.20-11.35 |
Host factors relevant for stratified dosing of TB drugs |
Prof. Jan-Willem Alffenaar |
|
11.35-11.50 |
Effective immune responses to mycobacteria what age can tell us |
Dr. Nicole L Messina |
|
11.50pm |
Lunch |
Session 3: Translating research into policy and practice (Chair: Justin Denholm)
|
Time |
Presentation title |
Speaker |
|
1pm |
Introduction |
Prof. Justin Denholm |
|
1.10pm |
Session 3.1: Translation into policy (15mins + 5mins Q&A) |
|
|
1.10-1.30 |
Bridging the Policy-Practice Gap in PNG: Towards ending TB in high-burden MDR-TB settings |
A/Prof. Suman Majumdar |
|
1:30-1.50 |
Managing adverse effects from TB therapy (Historical practice, Delphi guidelines, next steps) |
Dr. Kasha Singh |
|
1:50-2.10 |
Paediatric TB research to change policy |
Prof. Steve Graham |
|
2.10-2.15 |
Close |
Prof. Justin Denholm |
|
2.15 pm |
Session 3.2: TB clinical trials (10 mins+5 mins Q&A) |
A/Prof. Anna Coussens |
|
2.20-2.35 |
The SURE trial: towards reducing the burden of death and disability in children and adolescents with TBM |
Dr. Julie Huynh |
|
2.35-2.50 |
How frequently to monitor Drug resistant TB treatment? Improving the use of TB Trial data with an example from TB-PRACTECAL |
Dr. Philipp du Cros |
|
2.50-3.05 |
Host-Directed Therapies for Tuberculosis |
Dr. Gail Cross |
|
3:05-3:30 |
TB Clinical Trials: discussion of priorities and next steps |
Dr. Dani Lin |
|
3.30pm |
Tea break |
|
|
4.00-4.10 |
TB CRE and research collaboration in clinical and translational research |
Prof. Greg Fox |
|
4.10pm |
PhD student Session (3 minutes + 2 min Q&A) |
A/Prof Bernadette Saunders |
|
4.15-4.20 |
Structural variation discovery in Mycobacterium tuberculosis through pangenomics |
Aleix Baltrons |
|
4.20-4.25 |
Improving the detection of tuberculosis in pregnancy |
Alison Morton |
|
4.25-4.30 |
Catastrophic costs of TB in Australia |
Jemma Taylor |
|
4.30-4.35 |
Managing tuberculosis in Papua New Guinea: a personal experience |
Rendi Moke |
|
4.35-4.40 |
Is a model of care for Tuberculosis Infection Screening and Treatment in Primary Care possible in Australia? |
Madhumati Chatterji |
|
4.40-4.45 |
Developing precision RNA therapeutics for Tuberculosis |
Jan Schaefer |
|
4.45-4.50 |
Sensitive detection of mixed-strain Mtb infections with TBtypeR |
Jacob Munro |
|
4.50pm |
Close |
Session 1: World TB Day and research
|
Time |
Presentation title |
Speaker |
|
3.00pm |
Registration (10 mins) |
|
|
3.10-3.25 |
World TB Day Public Event (large meeting room) hosted by MTBC "Unite to End TB" (10mins + 5mins Q&A) |
Chair: Dr. Khai Huang |
|
3.25-3.40 |
Asymptomatic TB: Dispelling indoctrinated assumptions and reilluminating how We Can End TB |
A/Prof. Anna Coussens |
|
3.40-3.55 |
Experiential Experts - managing TB infection and family |
Krista Watts |
|
3.55-4.10 |
Maternal TB, what we know, what we need to do |
Prof. Steve Graham |
|
A TB research agenda to end TB (10mins + 5mins Q&A) |
||
|
4.10-4.15 |
Welcome and overview of TB research to end TB |
Prof. Greg Fox |
|
4.15-4.30 |
National TB research priorities overview |
Prof. Justin Denholm |
|
4.30-4.45 |
Regional TB research priorities overview |
Prof. Ben Marais |
|
4.45-5.00 |
Q&A: TB CRE |
Dr. Khai Huang |
|
5.00pm |
Close |
Session 2: New insights into tuberculosis host and pathogen (Chair: Sarah Dunstan)
|
Time |
Presentation title |
Speaker |
|
8.30am |
Registration |
|
|
Session 2.1: Pathogen (10mins + 5mins Q&A) |
||
|
9.00-9.15 |
Effect of compensatory evolution on the emergence and transmission of rifampicin-resistant TB in Cape Town, South Africa |
Prof. Helen Cox |
|
9.15-9.30 |
Predicting drug resistance direct from sputum using nanopore sequencing |
Mr. Lachlan Coin |
|
9.30-9.45 |
First national genomic characterisation of M. tuberculosis in Australia (AusPathogen) |
Dr. Kristy Horan |
|
9.45-10.00 |
Targeting Carbon Metabolism in Mycobacterium tuberculosis |
Dr. Ivanhoe Leung |
|
10.00-10.15 |
Optimising TB investments in Belarus, Moldova, Kyrgyz Republic, Tajikistan and Uzbekistan |
Dr. Rowan Martin-Hughes |
|
10.15-10.30 |
Impact of covid-19 on tuberculosis case detection in Viet Nam: a modelling analysis |
Long Bui |
|
10.30am |
Morning tea |
|
|
Session 2.2: Host |
Prof. Ben Marais |
|
|
10.50-11.05 |
Human and pathogen genomics of TB |
A/Prof. Sarah Dunstan |
|
11.05-11.20 |
Genome-wide association study reveals a novel tuberculosis susceptibility locus in multiple East Asian and European populations |
Dr. Shirley Chang |
|
11.20-11.35 |
Host factors relevant for stratified dosing of TB drugs |
Prof. Jan-Willem Alffenaar |
|
11.35-11.50 |
Effective immune responses to mycobacteria what age can tell us |
Dr. Nicole L Messina |
|
11.50pm |
Lunch |
Session 3: Translating research into policy and practice (Chair: Justin Denholm)
|
Time |
Presentation title |
Speaker |
|
1pm |
Introduction |
Prof. Justin Denholm |
|
1.10pm |
Session 3.1: Translation into policy (15mins + 5mins Q&A) |
|
|
1.10-1.30 |
Bridging the Policy-Practice Gap in PNG: Towards ending TB in high-burden MDR-TB settings |
A/Prof. Suman Majumdar |
|
1:30-1.50 |
Managing adverse effects from TB therapy (Historical practice, Delphi guidelines, next steps) |
Dr. Kasha Singh |
|
1:50-2.10 |
Paediatric TB research to change policy |
Prof. Steve Graham |
|
2.10-2.15 |
Close |
Prof. Justin Denholm |
|
2.15 pm |
Session 3.2: TB clinical trials (10 mins+5 mins Q&A) |
|
|
2.15-2.30 |
The SURE trial: towards reducing the burden of death and disability in children and adolescents with TBM |
Dr. Julie Huynh |
|
2.30-2.45 |
How frequently to monitor Drug resistant TB treatment? Improving the use of TB Trial data with an example from TB-PRACTECAL |
Dr. Philip du Cros |
|
2.45-3.00 |
Host-Directed Therapies for Tuberculosis |
Dr. Gail Cross |
|
3:00-3:30 |
TB Clinical Trials: discussion of priorities and next steps |
Dr. Dani Lin |
|
3.30pm |
Tea break |
|
|
4.00-4.10 |
TB CRE and research collaboration in clinical and translational research |
Prof. Greg Fox |
|
4.10pm |
PhD student Session (3 minutes + 2 min Q&A) |
|
|
4.10-4.15 |
Structural variation discovery in Mycobacterium tuberculosis through pangenomics |
Aleix Baltrons |
|
4.15-4.20 |
Improving the detection of tuberculosis in pregnancy |
Alison Morton |
|
4.20-4.25 |
Catastrophic costs of TB in Australia |
Jemma Taylor |
|
4.25-4.30 |
Managing tuberculosis in Papua New Guinea: a personal experience |
Rendi Moke |
|
4.30-4.35 |
Is a model of care for Tuberculosis Infection Screening and Treatment in Primary Care possible in Australia? |
Madhumati Chatterji |
|
4.35-4.40 |
Developing precision RNA therapeutics for Tuberculosis |
Jan Schaefer |
|
4.50pm |
Close |
|
|
|
|
We look forward to seeing you at the event. Thank you!
Best regards,
TB CRE Administrator
Centre of Research Excellence in Tuberculosis Control
Tickets for good, not greed Humanitix dedicates 100% of profits from booking fees to charity